Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Events entities : Tg therapeutics, inc. save search
TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferencePresentation scheduled for Tuesday, January 9, 2024, at 4:30 PM PT
Published: 2024-01-05 (Crawled : 13:30) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -2.5%
H: 12.69%
C: 11.84%
therapeutics
TG Therapeutics to Participate in the 2023 Jefferies Healthcare ConferenceFireside chat scheduled for Wednesday, June 7, 2023, at 11:30 AM ET
Published: 2023-06-05 (Crawled : 13:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -1.32%
H: 4.2%
C: -1.37%
therapeutics
TG Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare ConferencePresentation scheduled for Monday, January 9, 2023 at 9:45 AM PT
Published: 2023-01-06 (Crawled : 17:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 0.2%
H: 8.1%
C: 5.37%
therapeutics
TG Therapeutics to Host Conference Call on Third Quarter 2022 Financial Results and Business UpdateConference call to be held Thursday, November 10, 2022 at 8:30 AM ET
Published: 2022-11-08 (Crawled : 14:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 3.0%
H: 1.54%
C: -3.77%
conference therapeutics financial results
TG Therapeutics to Host Conference Call on Second Quarter 2022 Financial Results and Business UpdateConference call to be held Monday, August 8, 2022 at 8:30 AM ET
Published: 2022-08-05 (Crawled : 12:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -3.26%
H: 0.32%
C: -0.16%
conference therapeutics results
TG Therapeutics to Participate in the H.C. Wainwright Global Investment Conference Presentation available for on demand download beginning Tuesday May 24, 2022 at 7:00 AM ET
Published: 2022-05-20 (Crawled : 12:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -4.42%
H: 4.45%
C: -7.71%
conference therapeutics presentation
TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the American Academy of Neurology Annual Meeting
Published: 2022-03-04 (Crawled : 13:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -11.07%
H: 0.0%
C: 0.0%
america multiple sclerosis als trials trial therapeutics presentation sclerosis phase 3
TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2021 Financial Results and Business UpdateConference call to be held Tuesday, March 1, 2022 at 8:30 AM ET
Published: 2022-02-24 (Crawled : 14:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -3.82%
H: 0.0%
C: 0.0%
day financial results conference therapeutics results
TG Therapeutics to Participate in the B. Riley Securities 2022 Virtual Oncology Investor Conference
Published: 2022-01-24 (Crawled : 15:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -0.52%
H: 7.93%
C: 7.11%
conference therapeutics
TG Therapeutics Announces Combination Data Presentations at the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
Published: 2021-09-20 (Crawled : 12:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -2.05%
H: 3.68%
C: 2.06%
presentation leukemia
TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare ConferenceFireside chat scheduled for Wednesday, July 14, 2021 at 12:30 PM ET
Published: 2021-07-09 (Crawled : 14:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 0.8%
H: 3.94%
C: 3.44%
conference
TG Therapeutics Announces Data Presentations at Upcoming Medical Meetings
Published: 2021-05-13 (Crawled : 12:15) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 0.74%
H: 0.55%
C: -6.45%
presentation therapeutics
TG Therapeutics to Host Conference Call on First Quarter 2021 Financial Results and Business UpdateConference call to be held Monday, May 10, 2021 at 8:30 AM ET
Published: 2021-05-06 (Crawled : 12:15) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -1.04%
H: 0.6%
C: -2.92%
financial results results conference
TG Therapeutics to Host Investor & Analyst Event to Preview Results from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple SclerosisWebcast to be held tomorrow, April 16, 2021 at 8:30 AM ET
Published: 2021-04-15 (Crawled : 23:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 1.3%
H: 1.88%
C: 1.51%
multiple sclerosis results sclerosis phase 3 trial
TG Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
Published: 2021-03-04 (Crawled : 13:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 0.51%
H: 2.37%
C: -3.12%
life science
TG Therapeutics to Participate in the B. Riley Securities Oncology Investor ConferenceFireside chat scheduled for Wednesday, January 20, 2021 at 10:00 AM ET
Published: 2021-01-15 (Crawled : 13:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -0.31%
H: 0.99%
C: -2.76%
TG Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare ConferencePresentation scheduled for Tuesday, January 12, 2021 at 2:00 PM ET
Published: 2021-01-08 (Crawled : 13:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 2.64%
H: 1.08%
C: -2.01%
j.p. morgan healthcare conference
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.